Oxidative stress: a key modulator in neurodegenerative diseases

A Singh, R Kukreti, L Saso, S Kukreti - Molecules, 2019 - mdpi.com
Oxidative stress is proposed as a regulatory element in ageing and various neurological
disorders. The excess of oxidants causes a reduction of antioxidants, which in turn produce …

Basic mechanisms of neurodegeneration: a critical update

KA Jellinger - Journal of cellular and molecular medicine, 2010 - Wiley Online Library
Introduction• Protein aggregation‐'Toxic oligomer'hypothesis‐Protein (mis) folding‐
Proteostasis and molecular chaperones‐Protein misfolding and endoplasmic reticulum …

PARP-1 involvement in neurodegeneration: a focus on Alzheimer's and Parkinson's diseases

S Martire, L Mosca, M d'Erme - Mechanisms of ageing and development, 2015 - Elsevier
DNA damage is the prime activator of the enzyme poly (ADP-ribose) polymerase1 (PARP-1)
whose overactivation has been proven to be associated with the pathogenesis of numerous …

Toward understanding Machado–Joseph disease

M do Carmo Costa, HL Paulson - Progress in neurobiology, 2012 - Elsevier
Machado–Joseph disease (MJD), also known as spinocerebellar ataxia type 3 (SCA3), is
the most common inherited spinocerebellar ataxia and one of many polyglutamine …

Oxidative stress in neurodegenerative diseases: mechanisms and therapeutic perspectives

A Melo, L Monteiro, RMF Lima… - Oxidative medicine …, 2011 - Wiley Online Library
The incidence and prevalence of neurodegenerative diseases (ND) increase with life
expectancy. This paper reviews the role of oxidative stress (OS) in ND and pharmacological …

Machado–Joseph disease/spinocerebellar ataxia type 3: lessons from disease pathogenesis and clues into therapy

CA Matos, LP de Almeida… - Journal of …, 2019 - Wiley Online Library
Abstract Machado–Joseph disease (MJD), also known as spinocerebellar ataxia type 3
(SCA 3), is an incurable disorder, widely regarded as the most common form of …

Recent advances in our understanding of neurodegeneration

KA Jellinger - Journal of neural transmission, 2009 - Springer
Neurodegenerative diseases are featured by progressive dysfunction and death of cells in
selected areas in the nervous system, determining clinical presentation. Neuronal loss is …

An insight into the mechanism of antifungal activity of biogenic nanoparticles than their chemical counterparts

M Kumari, VP Giri, S Pandey, M Kumar… - Pesticide biochemistry …, 2019 - Elsevier
Herein, we describe the enhanced antifungal activity of silver nanoparticles biosynthesized
by cell free filtrate of Trichoderma viride (MTCC 5661) in comparison to chemically …

The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies

PO Bauer, N Nukina - Journal of neurochemistry, 2009 - Wiley Online Library
Expansion of CAG trinucleotide repeat within the coding region of several genes results in
the production of proteins with expanded polyglutamine (PolyQ) stretch. The expression of …

The CAG–polyglutamine repeat diseases: a clinical, molecular, genetic, and pathophysiologic nosology

CA Stoyas, AR La Spada - Handbook of clinical neurology, 2018 - Elsevier
Throughout the genome, unstable tandem nucleotide repeats can expand to cause a variety
of neurologic disorders. Expansion of a CAG triplet repeat within a coding exon gives rise to …